Click for best price
Coagulation Factor IX Market Size, Share 2024
| Market size in 2023 |
US$ 341.4 million
|
Forecast Market size by 2030 |
US$ 504.7 million
|
| Growth Rate |
CAGR of 6.1% |
Number of Pages |
103 Pages |
This research report provides a comprehensive analysis of the Coagulation Factor IX market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Coagulation Factor IX market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Coagulation Factor IX, challenges faced by the industry, and potential opportunities for market players.
The global Coagulation Factor IX market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Coagulation Factor IX market presents opportunities for various stakeholders, including Adult, Kids. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Coagulation Factor IX market. Additionally, the growing consumer demand present avenues for market expansion.
The global Coagulation Factor IX market was valued at US$ 341.4 million in 2023 and is projected to reach US$ 504.7 million by 2030, at a CAGR of 6.1% during the forecast period.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Key Features:
The research report on the Coagulation Factor IX market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Coagulation Factor IX market.
Market Overview: The report provides a comprehensive overview of the Coagulation Factor IX market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Coagulation Factor IX (Plasma Derived), Coagulation Factor IX (Recombinant)), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Coagulation Factor IX market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Coagulation Factor IX market's trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Coagulation Factor IX market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Coagulation Factor IX market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Coagulation Factor IX market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Coagulation Factor IX market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Coagulation Factor IX, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Coagulation Factor IX market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Coagulation Factor IX market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Coagulation Factor IX (Plasma Derived)
Coagulation Factor IX (Recombinant)
Market segment by Application
Adult
Kids
Global Coagulation Factor IX Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Pfizer
CSL Behring
Grifols
Novo Nordisk
Bioverativ
Sanquin
Takeda
Baxter
Aptevo
Outline of Major Chapters:
Chapter 1: Introduces the definition of Coagulation Factor IX, market overview.
Chapter 2: Global Coagulation Factor IX market size in revenue and volume.
Chapter 3: Detailed analysis of Coagulation Factor IX manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Coagulation Factor IX in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Coagulation Factor IX capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Coagulation Factor IX Market, Global Outlook and Forecast 2024-2030 |
| Market size in 2023 |
US$ 341.4 million
|
| Forecast Market size by 2030 |
US$ 504.7 million
|
| Growth Rate |
CAGR of 6.1% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
103 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Coagulation Factor IX Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Coagulation Factor IX Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Coagulation Factor IX Overall Market Size
2.1 Global Coagulation Factor IX Market Size: 2023 VS 2030
2.2 Global Coagulation Factor IX Revenue, Prospects & Forecasts: 2019-2030
2.3 Global Coagulation Factor IX Sales: 2019-2030
3 Company Landscape
3.1 Top Coagulation Factor IX Players in Global Market
3.2 Top Global Coagulation Factor IX Companies Ranked by Revenue
3.3 Global Coagulation Factor IX Revenue by Companies
3.4 Global Coagulation Factor IX Sales by Companies
3.5 Global Coagulation Factor IX Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Coagulation Factor IX Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Coagulation Factor IX Product Type
3.8 Tier 1, Tier 2 and Tier 3 Coagulation Factor IX Players in Global Market
3.8.1 List of Global Tier 1 Coagulation Factor IX Companies
3.8.2 List of Global Tier 2 and Tier 3 Coagulation Factor IX Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Coagulation Factor IX Market Size Markets, 2023 & 2030
4.1.2 Coagulation Factor IX (Plasma Derived)
4.1.3 Coagulation Factor IX (Recombinant)
4.2 By Type - Global Coagulation Factor IX Revenue & Forecasts
4.2.1 By Type - Global Coagulation Factor IX Revenue, 2019-2024
4.2.2 By Type - Global Coagulation Factor IX Revenue, 2025-2030
4.2.3 By Type - Global Coagulation Factor IX Revenue Market Share, 2019-2030
4.3 By Type - Global Coagulation Factor IX Sales & Forecasts
4.3.1 By Type - Global Coagulation Factor IX Sales, 2019-2024
4.3.2 By Type - Global Coagulation Factor IX Sales, 2025-2030
4.3.3 By Type - Global Coagulation Factor IX Sales Market Share, 2019-2030
4.4 By Type - Global Coagulation Factor IX Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Coagulation Factor IX Market Size, 2023 & 2030
5.1.2 Adult
5.1.3 Kids
5.2 By Application - Global Coagulation Factor IX Revenue & Forecasts
5.2.1 By Application - Global Coagulation Factor IX Revenue, 2019-2024
5.2.2 By Application - Global Coagulation Factor IX Revenue, 2025-2030
5.2.3 By Application - Global Coagulation Factor IX Revenue Market Share, 2019-2030
5.3 By Application - Global Coagulation Factor IX Sales & Forecasts
5.3.1 By Application - Global Coagulation Factor IX Sales, 2019-2024
5.3.2 By Application - Global Coagulation Factor IX Sales, 2025-2030
5.3.3 By Application - Global Coagulation Factor IX Sales Market Share, 2019-2030
5.4 By Application - Global Coagulation Factor IX Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global Coagulation Factor IX Market Size, 2023 & 2030
6.2 By Region - Global Coagulation Factor IX Revenue & Forecasts
6.2.1 By Region - Global Coagulation Factor IX Revenue, 2019-2024
6.2.2 By Region - Global Coagulation Factor IX Revenue, 2025-2030
6.2.3 By Region - Global Coagulation Factor IX Revenue Market Share, 2019-2030
6.3 By Region - Global Coagulation Factor IX Sales & Forecasts
6.3.1 By Region - Global Coagulation Factor IX Sales, 2019-2024
6.3.2 By Region - Global Coagulation Factor IX Sales, 2025-2030
6.3.3 By Region - Global Coagulation Factor IX Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America Coagulation Factor IX Revenue, 2019-2030
6.4.2 By Country - North America Coagulation Factor IX Sales, 2019-2030
6.4.3 US Coagulation Factor IX Market Size, 2019-2030
6.4.4 Canada Coagulation Factor IX Market Size, 2019-2030
6.4.5 Mexico Coagulation Factor IX Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe Coagulation Factor IX Revenue, 2019-2030
6.5.2 By Country - Europe Coagulation Factor IX Sales, 2019-2030
6.5.3 Germany Coagulation Factor IX Market Size, 2019-2030
6.5.4 France Coagulation Factor IX Market Size, 2019-2030
6.5.5 U.K. Coagulation Factor IX Market Size, 2019-2030
6.5.6 Italy Coagulation Factor IX Market Size, 2019-2030
6.5.7 Russia Coagulation Factor IX Market Size, 2019-2030
6.5.8 Nordic Countries Coagulation Factor IX Market Size, 2019-2030
6.5.9 Benelux Coagulation Factor IX Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia Coagulation Factor IX Revenue, 2019-2030
6.6.2 By Region - Asia Coagulation Factor IX Sales, 2019-2030
6.6.3 China Coagulation Factor IX Market Size, 2019-2030
6.6.4 Japan Coagulation Factor IX Market Size, 2019-2030
6.6.5 South Korea Coagulation Factor IX Market Size, 2019-2030
6.6.6 Southeast Asia Coagulation Factor IX Market Size, 2019-2030
6.6.7 India Coagulation Factor IX Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America Coagulation Factor IX Revenue, 2019-2030
6.7.2 By Country - South America Coagulation Factor IX Sales, 2019-2030
6.7.3 Brazil Coagulation Factor IX Market Size, 2019-2030
6.7.4 Argentina Coagulation Factor IX Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Coagulation Factor IX Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa Coagulation Factor IX Sales, 2019-2030
6.8.3 Turkey Coagulation Factor IX Market Size, 2019-2030
6.8.4 Israel Coagulation Factor IX Market Size, 2019-2030
6.8.5 Saudi Arabia Coagulation Factor IX Market Size, 2019-2030
6.8.6 UAE Coagulation Factor IX Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Coagulation Factor IX Major Product Offerings
7.1.4 Pfizer Coagulation Factor IX Sales and Revenue in Global (2019-2024)
7.1.5 Pfizer Key News & Latest Developments
7.2 CSL Behring
7.2.1 CSL Behring Company Summary
7.2.2 CSL Behring Business Overview
7.2.3 CSL Behring Coagulation Factor IX Major Product Offerings
7.2.4 CSL Behring Coagulation Factor IX Sales and Revenue in Global (2019-2024)
7.2.5 CSL Behring Key News & Latest Developments
7.3 Grifols
7.3.1 Grifols Company Summary
7.3.2 Grifols Business Overview
7.3.3 Grifols Coagulation Factor IX Major Product Offerings
7.3.4 Grifols Coagulation Factor IX Sales and Revenue in Global (2019-2024)
7.3.5 Grifols Key News & Latest Developments
7.4 Novo Nordisk
7.4.1 Novo Nordisk Company Summary
7.4.2 Novo Nordisk Business Overview
7.4.3 Novo Nordisk Coagulation Factor IX Major Product Offerings
7.4.4 Novo Nordisk Coagulation Factor IX Sales and Revenue in Global (2019-2024)
7.4.5 Novo Nordisk Key News & Latest Developments
7.5 Bioverativ
7.5.1 Bioverativ Company Summary
7.5.2 Bioverativ Business Overview
7.5.3 Bioverativ Coagulation Factor IX Major Product Offerings
7.5.4 Bioverativ Coagulation Factor IX Sales and Revenue in Global (2019-2024)
7.5.5 Bioverativ Key News & Latest Developments
7.6 Sanquin
7.6.1 Sanquin Company Summary
7.6.2 Sanquin Business Overview
7.6.3 Sanquin Coagulation Factor IX Major Product Offerings
7.6.4 Sanquin Coagulation Factor IX Sales and Revenue in Global (2019-2024)
7.6.5 Sanquin Key News & Latest Developments
7.7 Takeda
7.7.1 Takeda Company Summary
7.7.2 Takeda Business Overview
7.7.3 Takeda Coagulation Factor IX Major Product Offerings
7.7.4 Takeda Coagulation Factor IX Sales and Revenue in Global (2019-2024)
7.7.5 Takeda Key News & Latest Developments
7.8 Baxter
7.8.1 Baxter Company Summary
7.8.2 Baxter Business Overview
7.8.3 Baxter Coagulation Factor IX Major Product Offerings
7.8.4 Baxter Coagulation Factor IX Sales and Revenue in Global (2019-2024)
7.8.5 Baxter Key News & Latest Developments
7.9 Aptevo
7.9.1 Aptevo Company Summary
7.9.2 Aptevo Business Overview
7.9.3 Aptevo Coagulation Factor IX Major Product Offerings
7.9.4 Aptevo Coagulation Factor IX Sales and Revenue in Global (2019-2024)
7.9.5 Aptevo Key News & Latest Developments
8 Global Coagulation Factor IX Production Capacity, Analysis
8.1 Global Coagulation Factor IX Production Capacity, 2019-2030
8.2 Coagulation Factor IX Production Capacity of Key Manufacturers in Global Market
8.3 Global Coagulation Factor IX Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Coagulation Factor IX Supply Chain Analysis
10.1 Coagulation Factor IX Industry Value Chain
10.2 Coagulation Factor IX Upstream Market
10.3 Coagulation Factor IX Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Coagulation Factor IX Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Coagulation Factor IX in Global Market
Table 2. Top Coagulation Factor IX Players in Global Market, Ranking by Revenue (2023)
Table 3. Global Coagulation Factor IX Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global Coagulation Factor IX Revenue Share by Companies, 2019-2024
Table 5. Global Coagulation Factor IX Sales by Companies, (K Units), 2019-2024
Table 6. Global Coagulation Factor IX Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers Coagulation Factor IX Price (2019-2024) & (USD/Unit)
Table 8. Global Manufacturers Coagulation Factor IX Product Type
Table 9. List of Global Tier 1 Coagulation Factor IX Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Coagulation Factor IX Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Coagulation Factor IX Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Global Coagulation Factor IX Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global Coagulation Factor IX Revenue (US$, Mn), 2025-2030
Table 14. By Type - Global Coagulation Factor IX Sales (K Units), 2019-2024
Table 15. By Type - Global Coagulation Factor IX Sales (K Units), 2025-2030
Table 16. By Application ? Global Coagulation Factor IX Revenue, (US$, Mn), 2023 & 2030
Table 17. By Application - Global Coagulation Factor IX Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global Coagulation Factor IX Revenue (US$, Mn), 2025-2030
Table 19. By Application - Global Coagulation Factor IX Sales (K Units), 2019-2024
Table 20. By Application - Global Coagulation Factor IX Sales (K Units), 2025-2030
Table 21. By Region ? Global Coagulation Factor IX Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global Coagulation Factor IX Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global Coagulation Factor IX Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global Coagulation Factor IX Sales (K Units), 2019-2024
Table 25. By Region - Global Coagulation Factor IX Sales (K Units), 2025-2030
Table 26. By Country - North America Coagulation Factor IX Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America Coagulation Factor IX Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America Coagulation Factor IX Sales, (K Units), 2019-2024
Table 29. By Country - North America Coagulation Factor IX Sales, (K Units), 2025-2030
Table 30. By Country - Europe Coagulation Factor IX Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe Coagulation Factor IX Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe Coagulation Factor IX Sales, (K Units), 2019-2024
Table 33. By Country - Europe Coagulation Factor IX Sales, (K Units), 2025-2030
Table 34. By Region - Asia Coagulation Factor IX Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia Coagulation Factor IX Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia Coagulation Factor IX Sales, (K Units), 2019-2024
Table 37. By Region - Asia Coagulation Factor IX Sales, (K Units), 2025-2030
Table 38. By Country - South America Coagulation Factor IX Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America Coagulation Factor IX Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America Coagulation Factor IX Sales, (K Units), 2019-2024
Table 41. By Country - South America Coagulation Factor IX Sales, (K Units), 2025-2030
Table 42. By Country - Middle East & Africa Coagulation Factor IX Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa Coagulation Factor IX Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa Coagulation Factor IX Sales, (K Units), 2019-2024
Table 45. By Country - Middle East & Africa Coagulation Factor IX Sales, (K Units), 2025-2030
Table 46. Pfizer Company Summary
Table 47. Pfizer Coagulation Factor IX Product Offerings
Table 48. Pfizer Coagulation Factor IX Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 49. Pfizer Key News & Latest Developments
Table 50. CSL Behring Company Summary
Table 51. CSL Behring Coagulation Factor IX Product Offerings
Table 52. CSL Behring Coagulation Factor IX Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 53. CSL Behring Key News & Latest Developments
Table 54. Grifols Company Summary
Table 55. Grifols Coagulation Factor IX Product Offerings
Table 56. Grifols Coagulation Factor IX Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 57. Grifols Key News & Latest Developments
Table 58. Novo Nordisk Company Summary
Table 59. Novo Nordisk Coagulation Factor IX Product Offerings
Table 60. Novo Nordisk Coagulation Factor IX Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 61. Novo Nordisk Key News & Latest Developments
Table 62. Bioverativ Company Summary
Table 63. Bioverativ Coagulation Factor IX Product Offerings
Table 64. Bioverativ Coagulation Factor IX Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 65. Bioverativ Key News & Latest Developments
Table 66. Sanquin Company Summary
Table 67. Sanquin Coagulation Factor IX Product Offerings
Table 68. Sanquin Coagulation Factor IX Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 69. Sanquin Key News & Latest Developments
Table 70. Takeda Company Summary
Table 71. Takeda Coagulation Factor IX Product Offerings
Table 72. Takeda Coagulation Factor IX Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 73. Takeda Key News & Latest Developments
Table 74. Baxter Company Summary
Table 75. Baxter Coagulation Factor IX Product Offerings
Table 76. Baxter Coagulation Factor IX Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 77. Baxter Key News & Latest Developments
Table 78. Aptevo Company Summary
Table 79. Aptevo Coagulation Factor IX Product Offerings
Table 80. Aptevo Coagulation Factor IX Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 81. Aptevo Key News & Latest Developments
Table 82. Coagulation Factor IX Production Capacity (K Units) of Key Manufacturers in Global Market, 2022-2024 (K Units)
Table 83. Global Coagulation Factor IX Capacity Market Share of Key Manufacturers, 2022-2024
Table 84. Global Coagulation Factor IX Production by Region, 2019-2024 (K Units)
Table 85. Global Coagulation Factor IX Production by Region, 2025-2030 (K Units)
Table 86. Coagulation Factor IX Market Opportunities & Trends in Global Market
Table 87. Coagulation Factor IX Market Drivers in Global Market
Table 88. Coagulation Factor IX Market Restraints in Global Market
Table 89. Coagulation Factor IX Raw Materials
Table 90. Coagulation Factor IX Raw Materials Suppliers in Global Market
Table 91. Typical Coagulation Factor IX Downstream
Table 92. Coagulation Factor IX Downstream Clients in Global Market
Table 93. Coagulation Factor IX Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Coagulation Factor IX Segment by Type in 2023
Figure 2. Coagulation Factor IX Segment by Application in 2023
Figure 3. Global Coagulation Factor IX Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Coagulation Factor IX Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Coagulation Factor IX Revenue, 2019-2030 (US$, Mn)
Figure 7. Coagulation Factor IX Sales in Global Market: 2019-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Coagulation Factor IX Revenue in 2023
Figure 9. By Type - Global Coagulation Factor IX Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Type - Global Coagulation Factor IX Revenue Market Share, 2019-2030
Figure 11. By Type - Global Coagulation Factor IX Sales Market Share, 2019-2030
Figure 12. By Type - Global Coagulation Factor IX Price (USD/Unit), 2019-2030
Figure 13. By Application - Global Coagulation Factor IX Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Application - Global Coagulation Factor IX Revenue Market Share, 2019-2030
Figure 15. By Application - Global Coagulation Factor IX Sales Market Share, 2019-2030
Figure 16. By Application - Global Coagulation Factor IX Price (USD/Unit), 2019-2030
Figure 17. By Region - Global Coagulation Factor IX Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global Coagulation Factor IX Revenue Market Share, 2019 VS 2023 VS 2030
Figure 19. By Region - Global Coagulation Factor IX Revenue Market Share, 2019-2030
Figure 20. By Region - Global Coagulation Factor IX Sales Market Share, 2019-2030
Figure 21. By Country - North America Coagulation Factor IX Revenue Market Share, 2019-2030
Figure 22. By Country - North America Coagulation Factor IX Sales Market Share, 2019-2030
Figure 23. US Coagulation Factor IX Revenue, (US$, Mn), 2019-2030
Figure 24. Canada Coagulation Factor IX Revenue, (US$, Mn), 2019-2030
Figure 25. Mexico Coagulation Factor IX Revenue, (US$, Mn), 2019-2030
Figure 26. By Country - Europe Coagulation Factor IX Revenue Market Share, 2019-2030
Figure 27. By Country - Europe Coagulation Factor IX Sales Market Share, 2019-2030
Figure 28. Germany Coagulation Factor IX Revenue, (US$, Mn), 2019-2030
Figure 29. France Coagulation Factor IX Revenue, (US$, Mn), 2019-2030
Figure 30. U.K. Coagulation Factor IX Revenue, (US$, Mn), 2019-2030
Figure 31. Italy Coagulation Factor IX Revenue, (US$, Mn), 2019-2030
Figure 32. Russia Coagulation Factor IX Revenue, (US$, Mn), 2019-2030
Figure 33. Nordic Countries Coagulation Factor IX Revenue, (US$, Mn), 2019-2030
Figure 34. Benelux Coagulation Factor IX Revenue, (US$, Mn), 2019-2030
Figure 35. By Region - Asia Coagulation Factor IX Revenue Market Share, 2019-2030
Figure 36. By Region - Asia Coagulation Factor IX Sales Market Share, 2019-2030
Figure 37. China Coagulation Factor IX Revenue, (US$, Mn), 2019-2030
Figure 38. Japan Coagulation Factor IX Revenue, (US$, Mn), 2019-2030
Figure 39. South Korea Coagulation Factor IX Revenue, (US$, Mn), 2019-2030
Figure 40. Southeast Asia Coagulation Factor IX Revenue, (US$, Mn), 2019-2030
Figure 41. India Coagulation Factor IX Revenue, (US$, Mn), 2019-2030
Figure 42. By Country - South America Coagulation Factor IX Revenue Market Share, 2019-2030
Figure 43. By Country - South America Coagulation Factor IX Sales Market Share, 2019-2030
Figure 44. Brazil Coagulation Factor IX Revenue, (US$, Mn), 2019-2030
Figure 45. Argentina Coagulation Factor IX Revenue, (US$, Mn), 2019-2030
Figure 46. By Country - Middle East & Africa Coagulation Factor IX Revenue Market Share, 2019-2030
Figure 47. By Country - Middle East & Africa Coagulation Factor IX Sales Market Share, 2019-2030
Figure 48. Turkey Coagulation Factor IX Revenue, (US$, Mn), 2019-2030
Figure 49. Israel Coagulation Factor IX Revenue, (US$, Mn), 2019-2030
Figure 50. Saudi Arabia Coagulation Factor IX Revenue, (US$, Mn), 2019-2030
Figure 51. UAE Coagulation Factor IX Revenue, (US$, Mn), 2019-2030
Figure 52. Global Coagulation Factor IX Production Capacity (K Units), 2019-2030
Figure 53. The Percentage of Production Coagulation Factor IX by Region, 2023 VS 2030
Figure 54. Coagulation Factor IX Industry Value Chain
Figure 55. Marketing Channels
